Gain Therapeutics Inc (GANX) short volume · $53.0M cap
Gain Therapeutics Inc FINRA short-volume cache. Latest 2026-10-21.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-10-21 | 156,435 | 396,618 | 39.4% |
| 2026-10-20 | 104,174 | 304,742 | 34.2% |
| 2026-10-19 | 198,857 | 391,545 | 50.8% |
| 2026-10-16 | 160,814 | 272,978 | 58.9% |
| 2026-10-15 | 202,010 | 393,790 | 51.3% |
| 2026-10-14 | 260,649 | 541,481 | 48.1% |
| 2026-10-13 | 268,577 | 572,625 | 46.9% |
| 2026-10-12 | 137,765 | 188,562 | 73.1% |
| 2026-10-09 | 148,734 | 186,771 | 79.6% |
| 2026-10-08 | 111,563 | 231,349 | 48.2% |
GANX short volume FAQ
What was GANX's latest FINRA short volume?
On Oct 21, 2026, cached FINRA short volume for Gain Therapeutics Inc (GANX) was 156,435 shares, 39.4% of 396,618 total volume.
How many GANX short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Gain Therapeutics Inc (GANX), from Oct 8, 2026 through Oct 21, 2026.
How did GANX short volume percent change from the prior cached session?
Cached FINRA short volume for Gain Therapeutics Inc (GANX) moved from 34.2% on Oct 20, 2026 to 39.4% on Oct 21, 2026, up 5.2 percentage points.
What was the highest GANX short volume percent on this page?
The highest cached FINRA short volume on this page is 79.6% of total volume on Oct 9, 2026.
What is GANX's latest revenue?
Latest cached Gain Therapeutics Inc (GANX) revenue for Sep 30, 2023 was $55.2K. Statements: https://lician.com/financials/ganx
What is the average GANX short volume percent on this page?
Across 10 cached sessions on this page, Gain Therapeutics Inc (GANX) short volume averaged 53.1% of total volume.
Where is GANX short volume listed?
Cached FINRA short volume for Gain Therapeutics Inc (GANX) is listed at https://lician.com/short-interest/ganx.
Not investment advice. Cached rows, not a live tape.